Clinical Trial Update: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of everolimus in patients with pancreatic neuroendocrine tumors with liver metastases, previously treated with surgery; study terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Gastrinoma, Glucagonoma | Phase 2 | Status: TERMINATED | Results posted: 2020-12-02